The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
暂无分享,去创建一个
M. Diccianni | A. Batova | A. Yu | John Yu | A. Nudelman | A. Rephaeli | Tetsuya Tanaka | L. Shao
暂无分享,去创建一个
M. Diccianni | A. Batova | A. Yu | John Yu | A. Nudelman | A. Rephaeli | Tetsuya Tanaka | L. Shao